drugset

drugset / Trial / NCT04808323

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

NCT04808323 ↗

Phase 1 Recruiting 22 enrolled Medical College of Wisconsin

Non-randomizedSequentialOpen-labelTreatment

Summary

This study is a prospective, open-label, phase I design.

Timeline

Start: 2021-06-17
Primary completion: 2027-04-14
Completion: 2029-01-20

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Capecitabine	Small molecule	825 mg/m2	—

Indications